Skip to main content
Hit enter to search or ESC to close
Study of safety and effectiveness of topical administration (eye drops) of sitagliptin for treating early stages of diabetic retinopathy (EyeSit@)
© 2022 VHIR Annual Report 2021.
Six Top Stories
Facts & Figures
Partners and Acknowledgements
VHIR Annual Report 2021